Last week we wrote about Jane Brody s New York Times article on solutions for cognitive decline. And this week, she covers cognitive decline once again, this time focusing on different tests for early signs of dementia.
A new paper published in JAMA Internal Medicine makes an interesting claim that a class of drugs called anticholinergics may cause dementia and Alzheimer s disease.
The latest in health news: Consumers want GMO labels, but few know the facts, flu season is the worst one yet and failed flu shot to blame, & a class of drugs called anticholinergics have been linked to dementia later in life.
The latest in health news: Attack on sugary drinks is back, Alzheimer's in a dish for research, and why rapid weight loss may not result in weight gain just as fast
For the first time, researchers created what they call Alzheimer s in a Dish human brain cells that develop defining Alzheimer s structures in a petri dish. This incredible achievement could redefine how Alzheimer s and potential treatment drugs are studied. Until now, researchers were only able to use mice that developed an imperfect form of the disease.
Recently, the FDA has approved new PET tracers as clinical tools to estimate brain amyloid burden in patients being evaluated for cognitive impairment or dementia. And these new tracers - tau-protein tracers - may be
Benzodiazepines are drugs that are commonly prescribed to combat anxiety, or as sedatives and muscle relaxants. They include Xanax, Librium, Valium, and Halcion, and several others. We ve known the up-and-downsides of such drugs for many years, as well as their addictive tendencies. But a new study provides concern that we might need to add another risk to that list.